Company: EDSA
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001171843-25-002028
Chunk: 54

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 54
---
 sustained financial performance; and |

| ● | aligning our executives’ interests with those of our shareholders to create long-term value. |

Q: What are the effects of these votes?

A: Proposal 2 is advisory, and non-binding on our Board. However, the Board and the Compensation Committee will review and consider the results of these votes when evaluating our executive compensation program.

Proposal 2 is as follows:

“Resolved, that the compensation of the Company’s named executive officers, as described in the Company’s proxy statement for the 2025 Annual Meeting of Shareholders, including the various compensation tables and the related narrative disclosures, is hereby APPROVED.”

Vote Required

Proposal 2 requires the affirmative vote of the holders of a majority of shares present in person or represented by proxy at the Annual Meeting and entitled to vote. Shares that are not represented at the Annual Meeting, abstentions, if any, and, if this proposal is deemed to be “non-routine,” broker non-votes with respect to this proposal will not affect the outcome of the vote on this proposal. If this proposal is deemed to be “routine,” no broker non-votes will occur on this proposal.

<div align='center'>THE BOARD RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR THE ADVISORY APPROVAL OF OUR NAMED EXECUTIVE OFFICERS' COMPENSATION

33

PROPOSAL 3: TO APPROVE OF AN AMENDMENT TO OUR 2019 PLAN TO (I) INCREASE THE NUMBER OF COMMON SHARES AUTHORIZED FOR ISSUANCE THEREUNDER FROM 642,737 TO 1,725,000 (II) REMOVE THE PLAN’S FUNGIBLE SHARE POOL PROVISIONS AND (III) INCREASES THE NUMBER OF SHARES ISSUABLE UNDER THE 2019 PLAN AS INCENTIVE STOCK OPTIONS FROM 171,429 TO 300,000</div>

Edesa shareholders are being asked to approve an amendment to the 2019 Plan, that (i) increases the number of Edesa common shares issuable under the 2019 Plan by 1,725,000 shares, (ii) removes the 2019 Plan’s “fungible share pool” provisions (described below) and (iii) increases the number of Edesa common shares issuable under the 2019 Plan as “incentive stock options” (or “ISOs”), which are intended to qualify under Section 422 of the U.S. Internal Revenue Code of 1986, as